Literature DB >> 1861211

Liver involvement in Alpers disease.

M R Narkewicz1, R J Sokol, B Beckwith, J Sondheimer, A Silverman.   

Abstract

Alpers disease consists of diffuse cerebral degeneration manifested as developmental delay, seizures, vomiting, and progressive neuromuscular deterioration, with liver disease and death. We report the clinical course of the liver disease, histologic progression of the hepatic lesions, and etiologic investigations in five patients (four girls, three kinships). All had grown and developed normally until seen at 6 to 36 months of age (mean 20 months), with vomiting (n = 5), progressive hypotonia (n = 3), or seizures (n = 2). All had been given anticonvulsants, including valproic acid in three. Liver disease was noted at a mean age of 35 months (range 9 to 67 months), with hepatomegaly (two patients), abnormal hepatic synthetic function (three) or transaminase values (three), and cirrhosis in one. Patients survived for a mean of 4.6 weeks (range 1 to 8 weeks) after the identification of liver disease; all died of hepatic failure. Results of evaluation for infectious and metabolic causes of liver disease and causes of degenerative neuromuscular disease were negative in all patients. Premortem liver biopsy specimens (n = 3) demonstrated an early lesion consisting of lobular disarray, microvesicular steatosis, periportal acute and chronic inflammation, and individual hepatocyte necrosis. Autopsy findings (n = 5) consisted of macrovesicular steatosis, massive hepatocyte dropout, and proliferation of bile ductular elements, with almost complete replacement of hepatocytes by proliferating bile ductular elements in two patients. Brain showed characteristic neuronal degeneration. We conclude that Alpers disease can be a cause of rapidly progressive liver failure in early childhood. Although the cause of this autosomal recessive disease is not known, it does not appear to be related to peroxisomal dysfunction.

Entities:  

Mesh:

Year:  1991        PMID: 1861211     DOI: 10.1016/s0022-3476(05)80736-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content.

Authors:  Markus M Lindroos; Ronald Borra; Nina Mononen; Terho Lehtimäki; Kirsi A Virtanen; Virva Lepomäki; Letizia Guiducci; Patricia Iozzo; Kari Majamaa; Pirjo Nuutila
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

2.  Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2013-06-28       Impact factor: 4.406

3.  Progressive neuronal degeneration of childhood (Alpers syndrome) with hepatic cirrhosis.

Authors:  D C Wilson; D McGibben; E M Hicks; I V Allen
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

Review 4.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 5.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

Review 6.  Gastrointestinal manifestations of mitochondrial disorders: a systematic review.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Therap Adv Gastroenterol       Date:  2016-10-06       Impact factor: 4.409

Review 7.  Mitochondrial hepatopathy: Respiratory chain disorders- 'breathing in and out of the liver'.

Authors:  Amrit Gopan; Moinak Sen Sarma
Journal:  World J Hepatol       Date:  2021-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.